Sun Pharma can manufacture and export semaglutide, but not sell in India: Delhi High Court
The Delhi High Court has allowed Sun Pharmaceutical Industries Ltd. to manufacture and export its semaglutide-based drug, which is similar to Novo Nordisk’s Ozempic, while prohibiting its sale within India. The court’s order permits the company to supply the drug to international markets where patent restrictions do not apply, ensuring compliance with intellectual property rights….
